6128 results
Cited 6 times since 2019 (1.1 per year)
source: EuropePMC
Interactive cardiovascular and thoracic surgery,
Volume 29, Issue 3, 1 1 2019, Pages 461-468
A 45-year experience with the Fontan procedure: tachyarrhythmia, an important sign for adverse outcome.
Rijnberg FM, Blom NA, Sojak V, Bruggemans EF, Kuipers IM, Rammeloo LAJ, Jongbloed MRM, Bouma BJ, Hazekamp MG
Objectives: This study aims to evaluate our 45-year experience with the Fontan procedure and to identify risk factors for late mortality and morbidity. Methods: Demographic, preoperative, perioperative and postoperative characteristics were retrospectively collected for all patients who underwent a Fontan procedure in a single centre between 1972 and 2016. Results: The study included 277 Fontan procedures (44 atriopulmonary connections, 28 Fontan-Björk, 42 lateral tunnels and 163 extracardiac co...
Abstract
Cited 19 times since 2019 (3.5 per year)
source: EuropePMC
Journal of the American College of Cardiology,
Volume 74, Issue 9, 1 1 2019, Pages 1177-1186
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery.
Goodman SG, Aylward PE, Szarek M, Chumburidze V, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Hanotin C, Harrington RA, Jukema JW, Kedev S, Letierce A, Moryusef A, Pordy R, Ramos López GA, Roe MT, Viigimaa M, White HD, Zeiher AM, Steg PG, Schwartz GG, ODYSSEY OUTCOMES Committees and Investigators
Background: Patients with acute coronary syndrome (ACS) and history of coronary artery bypass grafting (CABG) are at high risk for recurrent cardiovascular events and death. Objectives: This study sought to determine the clinical benefit of adding alirocumab to statins in ACS patients with prior CABG in a pre-specified analysis of ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab). Methods: Patients (n = 18,924) 1 to 12 mont...
Abstract
Cited 10 times since 2019 (1.8 per year)
source: EuropePMC
European heart journal. Cardiovascular Imaging,
Volume 20, Issue 9, 1 1 2019, Pages 963-966
Criteria for surveys: from the European Association of Cardiovascular Imaging Scientific Initiatives Committee.
Haugaa KH, Marsan NA, Cameli M, D'Andrea A, Dweck MR, Carvalho RF, Holte E, Manka R, Michalski B, Podlesnikar T, Popescu BA, Schulz-Menger J, Sitges M, Stankovic I, Maurer G, Edvardsen T
The European Association of Cardiovascular Imaging (EACVI) is committed to maintaining the highest standards of professional excellence in all aspects of cardiovascular imaging. The mission of the EACVI is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging with a particular focus on education, training, scientific initiatives, and research. The EACVI established the Scientific Initiatives Committee (SIC) in December 2018. This co...
Abstract
Cited 27 times since 2019 (4.9 per year)
source: EuropePMC
European heart journal,
Volume 40, Issue 33, 1 1 2019, Pages 2801-2809
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
White HD, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Erglis A, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lopes RD, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Sritara P, Tricoci P, Zeiher AM, Schwartz GG, ODYSSEY OUTCOMES Investigators
Aims: The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related to oxygen supply/demand imbalance; Type 3, fatal without ascertainment of cardiac biomarkers; Type 4, related to percutaneous coronary intervention; and Type 5, related to coronary artery bypass surgery. Low-density lipoprotein cholesterol (LDL-C) reduction with statins and proprotein convertase subtilisin-kexin Type 9 (PCSK9) inhibitors reduces risk...
Abstract
Cited 7 times since 2019 (1.3 per year)
source: EuropePMC
Pacing and clinical electrophysiology : PACE,
Volume 42, Issue 10, 30 5 2019, Pages 1365-1373
Influence of risk factors in the ESC-EHRA EORP atrial fibrillation ablation long-term registry.
Trines SA, Stabile G, Arbelo E, Dagres N, Brugada J, Kautzner J, Pokushalov E, Maggioni AP, Laroche C, Anselmino M, Beinart R, Traykov V, Blomström-Lundqvist C, ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry investigators
Background: The influence of risk factors on atrial fibrillation (AF) ablation recurrence is increasingly recognized. We present a sub-analysis of the European Society of Cardiology-European Heart Rhythm Association-European Society of Cardiology AF ablation long-term registry on the effect of traditional risk factors for AF on postablation recurrence, reablation, and complications using real-world data. Methods: Risk factors for AF were defined as body mass index ≥27 kg/m², hypertension, chroni...
Abstract
Cited 4 times since 2019 (0.7 per year)
source: EuropePMC
Journal of cardiovascular computed tomography,
Volume 13, Issue 5, 30 5 2019, Pages 235-241
Noninvasive assessment of coronary atherosclerosis by cardiac computed tomography for risk stratifying patients with suspected coronary heart disease.
van Rosendael AR, Bax JJ, Arbab-Zadeh A
Abstract
Cited 3 times since 2019 (0.5 per year)
source: EuropePMC
The Journal of thoracic and cardiovascular surgery,
Volume 160, Issue 2, 28 4 2019, Pages 399-405
Clamping versus nonclamping thoracoscopic box ablation in long-standing persistent atrial fibrillation.
Harlaar N, Verberkmoes NJ, van der Voort PH, Trines SA, Verstraeten SE, Mertens BJA, Klautz RJM, Braun J, van Brakel TJ
Objective: To compare clinical outcomes of clamping devices and linear nonclamping devices for isolation of the posterior left atrium (box) in thoracoscopic ablation of long-standing persistent atrial fibrillation. Methods: Eighty patients who underwent thoracoscopic pulmonary vein and box isolation using a bipolar clamping device (42 patients) or bipolar nonclamping device (38 patients) to create the roof/inferior lesions for box isolation were included from 2 centers. Follow-up consisted of 24...
Abstract
Cited 10 times since 2019 (1.8 per year)
source: EuropePMC
PLoS computational biology,
Volume 15, Issue 8, 28 4 2019, Pages e1006697
Tracking Pseudomonas aeruginosa transmissions due to environmental contamination after discharge in ICUs using mathematical models.
Pham TM, Kretzschmar M, Bertrand X, Bootsma M, COMBACTE-MAGNET Consortium
Pseudomonas aeruginosa (P. aeruginosa) is an important cause of healthcare-associated infections, particularly in immunocompromised patients. Understanding how this multi-drug resistant pathogen is transmitted within intensive care units (ICUs) is crucial for devising and evaluating successful control strategies. While it is known that moist environments serve as natural reservoirs for P. aeruginosa, there is little quantitative evidence regarding the contribution of environmental contamination...
Abstract
Cited 5 times since 2019 (0.9 per year)
source: EuropePMC
JACC. Clinical electrophysiology,
Volume 5, Issue 10, 28 4 2019, Pages 1115-1126
New Adjusted Cutoffs for "Normal" Endocardial Voltages in Patients With Post-Infarct LV Remodeling.
Sramko M, Abdel-Kafi S, van der Geest RJ, de Riva M, Glashan CA, Lamb HJ, Zeppenfeld K
Objectives: This study sought to determine new reference cutoffs for normal unipolar voltage (UV) and bipolar voltage (BV) that would be adjusted for the LV remodeling. Background: The definition of "normal" left ventricular (LV) endocardial voltage in patients with post-infarct scar is still lacking. The reference voltage of the noninfarcted myocardium (NIM) may differ between patients depending on LV structural remodeling and the ensuing interstitial fibrosis. Methods: Electroanatomi...
Abstract
Cited 14 times since 2019 (2.5 per year)
source: EuropePMC
European journal of heart failure,
Volume 21, Issue 11, 27 4 2019, Pages 1469-1472
Prediction of short- and long-term mortality in takotsubo syndrome: the InterTAK Prognostic Score.
Wischnewsky MB, Candreva A, Bacchi B, Cammann VL, Kato K, Szawan KA, Gili S, D'Ascenzo F, Dichtl W, Citro R, Bossone E, Neuhaus M, Franke J, Sorici-Barb I, Jaguszewski M, Noutsias M, Knorr M, Heiner S, Burgdorf C, Kherad B, Tschöpe C, Sarcon A, Shinbane J, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Karakas M, Koenig W, Pott A, Meyer P, Arroja JD, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Napp LC, Budnik M, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Chan C, Bridgman P, Beug D, Delmas C, Lairez O, El-Battrawy I, Akin I, Gilyarova E, Shilova A, Gilyarov M, Kozel M, Tousek P, Winchester DE, Galuszka J, Ukena C, Poglajen G, Carrilho-Ferreira P, Hauck C, Paolini C, Bilato C, Prasad A, Rihal CS, Liu K, Schulze PC, Bianco M, Jörg L, Rickli H, Nguyen TH, Kobayashi Y, Böhm M, Maier LS, Pinto FJ, Widimský P, Borggrefe M, Felix SB, Opolski G, Braun-Dullaeus RC, Rottbauer W, Hasenfuß G, Pieske BM, Schunkert H, Thiele H, Bauersachs J, Katus HA, Horowitz J, Di Mario
Abstract
Cited 8 times since 2019 (1.4 per year)
source: EuropePMC
The American journal of cardiology,
Volume 124, Issue 9, 23 4 2019, Pages 1397-1405
Risk Reclassification With Coronary Computed Tomography Angiography-Visualized Nonobstructive Coronary Artery Disease According to 2018 American College of Cardiology/American Heart Association Cholesterol Guidelines (from the Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes : An International Multicenter Registry [CONFIRM]).
Han D, Beecy A, Anchouche K, Gransar H, Dunham PC, Lee JH, Achenbach S, Al-Mallah MH, Andreini D, Berman DS, Bax JJ, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chinnaiyan K, Chow BJW, Cury RC, DeLago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann PA, Kim YJ, Leipsic JA, Maffei E, Marques H, de Araújo Gonçalves P, Pontone G, Raff GL, Rubinshtein R, Villines TC, Lu Y, Peña JM, Shaw LJ, Min JK, Lin FY
The 2018 American College of Cardiology (ACC)/American Heart Association (AHA) cholesterol management guideline recommends risk enhancers in the borderline-risk and statin recommended/intermediate-risk groups. We determined the risk reclassification by the presence and severity of coronary computed tomography angiography (CCTA)-visualized coronary artery disease (CAD) according to statin eligibility groups. Of 35,281 individuals who underwent CCTA, 1,303 asymptomatic patients (age 59, 65% male)...
Abstract
Cited 148 times since 2019 (26.7 per year)
source: EuropePMC
Nature communications,
Volume 10, Issue 1, 20 3 2019, Pages 3346
A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals.
Deelen J, Kettunen J, Fischer K, van der Spek A, Trompet S, Kastenmüller G, Boyd A, Zierer J, van den Akker EB, Ala-Korpela M, Amin N, Demirkan A, Ghanbari M, van Heemst D, Ikram MA, van Klinken JB, Mooijaart SP, Peters A, Salomaa V, Sattar N, Spector TD, Tiemeier H, Verhoeven A, Waldenberger M, Würtz P, Davey Smith G, Metspalu A, Perola M, Menni C, Geleijnse JM, Drenos F, Beekman M, Jukema JW, van Duijn CM, Slagboom PE
Predicting longer-term mortality risk requires collection of clinical data, which is often cumbersome. Therefore, we use a well-standardized metabolomics platform to identify metabolic predictors of long-term mortality in the circulation of 44,168 individuals (age at baseline 18-109), of whom 5512 died during follow-up. We apply a stepwise (forward-backward) procedure based on meta-analysis results and identify 14 circulating biomarkers independently associating with all-cause mortality. Overall...
Abstract
Cited 32 times since 2019 (5.8 per year)
source: EuropePMC
Molecular nutrition & food research,
Volume 64, Issue 15, 16 3 2019, Pages e1900732
Akkermansia muciniphila Exerts Lipid-Lowering and Immunomodulatory Effects without Affecting Neointima Formation in Hyperlipidemic APOE*3-Leiden.CETP Mice.
Katiraei S, de Vries MR, Costain AH, Thiem K, Hoving LR, van Diepen JA, Smits HH, Bouter KE, Rensen PCN, Quax PHA, Nieuwdorp M, Netea MG, de Vos WM, Cani PD, Belzer C, van Dijk KW, Berbée JFP, van Harmelen V
Scope: Akkermansia muciniphila (A. muciniphila) is an intestinal commensal with anti-inflammatory properties both in the intestine and other organs. The aim is to investigate the effects of oral administration of A. muciniphila on lipid metabolism, immunity, and cuff-induced neointima formation in hyperlipidemic APOE*3-Leiden (E3L).CETP mice. Methods and results: Hyperlipidemic male E3L.CETP mice are daily treated with 2 × 108 CFU A. muciniphila by oral gavage for 4 weeks and the effects are det...
Abstract
Cited 7 times since 2019 (1.3 per year)
source: EuropePMC
Circulation. Cardiovascular imaging,
Volume 12, Issue 8, 15 3 2019, Pages e009586
Global and Regional Longitudinal Strain Assessment in Hypertrophic Cardiomyopathy.
Delgado V, Ajmone Marsan N
Abstract
Cited 1 times since 2019 (0.2 per year)
source: EuropePMC
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,
Volume 15, Issue 6, 9 2 2019, Pages e484-e485
Prosthetic valve endocarditis after surgical and transcatheter aortic valve replacement: infrequent, but poor outcome.
Bax JJ, Delgado V
Abstract
Cited 7 times since 2019 (1.3 per year)
source: EuropePMC
Neurobiology of aging,
Volume 84, 9 2 2019, Pages 236.e17-236.e28
Repeat variations in polyglutamine disease-associated genes and cognitive function in old age.
Gardiner SL, Trompet S, Sabayan B, Boogaard MW, Jukema JW, Slagboom PE, Roos RAC, van der Grond J, Aziz NA
Although the heritability of cognitive function in old age is substantial, genome-wide association studies have had limited success in elucidating its genetic basis, leaving a considerable amount of "missing heritability." Aside from single nucleotide polymorphisms, genome-wide association studies are unable to assess other large sources of genetic variation, such as tandem repeat polymorphisms. Therefore, here, we studied the association of cytosine-adenine-guanine (CAG) repeat variat...
Abstract
Cited 14 times since 2019 (2.5 per year)
source: EuropePMC
Frontiers in cardiovascular medicine,
Volume 6, 8 2 2019, Pages 113
miRMap: Profiling 14q32 microRNA Expression and DNA Methylation Throughout the Human Vasculature.
Goossens EAC, de Vries MR, Simons KH, Putter H, Quax PHA, Nossent AY
Aims: MicroRNAs are regulators of (patho)physiological functions with tissue-specific expression patterns. However, little is known about inter-vascular differences in microRNA expression between blood vessel types or vascular beds. Differences in microRNA expression could influence cardiovascular pathophysiology at specific sites in the vasculature. Therefore, we aimed to map expression profiles of vasoactive 14q32 microRNAs throughout the human vasculature, as well as expression of vasoactive...
Abstract
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,
Volume 58, Issue 4, 6 1 2019, Pages 495-501
Factors Associated with Hospital Dependent Delay to Carotid Endarterectomy in the Dutch Audit for Carotid Interventions.
Kuhrij LS, Meershoek AJA, Karthaus EG, Vahl AC, Hamming JF, Nederkoorn PJ, de Borst GJ
Objectives: As the risk of a recurrent neurological event in patients with symptomatic carotid stenosis requiring carotid endarterectomy (CEA) is highest in the early phase after the first neurological event, guidelines recommend operating on these patients as soon as possible or at least within 14 days of their initial event. However, in real world practice this is often not met. The aim of this study is to identify factors that cause hospital dependent delay to CEA. Methods: All consecutive pa...
Abstract
Cited 2 times since 2019 (0.4 per year)
source: EuropePMC
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
Volume 28, Issue 4, 5 1 2019, Pages 1983-1989
The usefulness of preoperative exercise therapy in patients scheduled for lung cancer surgery; a survey among Dutch pulmonologists and cardiothoracic surgeons.
Pouwels S, Topal B, Ter Woorst JF, Buise MP, Shahin GM, Spruit MA, Smeenk FWJM
Background: Preoperative exercise training (PET) studies show promising results in various patient populations. However, the lack of standardised programmes and uniformity in practice guidelines are barriers for implementation. Aim of this study was to assess the current opinions of pulmonologists and cardiothoracic surgeons on the clinical applicability of PET in patients scheduled for lung cancer surgery. Methods: Dutch pulmonologists and cardiothoracic surgeons were asked to complete a 29-que...
Abstract
Cited 1 times since 2019 (0.2 per year)
source: EuropePMC
European journal of hybrid imaging,
Volume 3, Issue 1, 2 1 2019, Pages 14
Characterization of the left ventricular arrhythmogenic substrate with multimodality imaging: role of innervation imaging and left ventricular global longitudinal strain.
El Mahdiui M, Smit JM, van Rosendael AR, Delgado V, Ajmone Marsan N, Jukema JW, Scholte AJHA, Bax JJ
Background: Even though implantable cardioverter defibrillator (ICD) implantation for primary prevention has shown to reduce the risk of sudden cardiac death in chronic heart failure patients with reduced left ventricular ejection fraction (LVEF), a significant portion of these patients will never receive appropriate ICD therapy. We aimed to functionally characterize the arrhythmogenic substrate using left ventricular (LV) global longitudinal strain (GLS) and heart-to-mediastinum (H/M) ratio on...
Abstract
